Head and Neck Diseases by Alexandros G.Sfakianakis: Letter to the Editor submitted in response to "The Extinction of Topical Erythromycin Therapy for Acne Vulgaris and Concern for the Future of Topical Clindamycin."

Σάββατο 27 Μαΐου 2017

Letter to the Editor submitted in response to "The Extinction of Topical Erythromycin Therapy for Acne Vulgaris and Concern for the Future of Topical Clindamycin."

Letter to the Editor submitted in response to "The Extinction of Topical Erythromycin Therapy for Acne Vulgaris and Concern for the Future of Topical Clindamycin."

J Dermatolog Treat. 2017 May 26;:1-9

Authors: Gupta T, Sardana K, Kumar B, Gautam HK

PMID: 28545314 [PubMed - as supplied by publisher]

http://ift.tt/2qtE5m5

Head and Neck Diseases by Alexandros G.Sfakianakis

Σάββατο 27 Μαΐου 2017

Letter to the Editor submitted in response to "The Extinction of Topical Erythromycin Therapy for Acne Vulgaris and Concern for the Future of Topical Clindamycin."

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου